FY2025 · ended Dec 31, 2025 · Revenue $2.76B, +3.1% YoY · Filed Feb 20, 2026
Accendra Health, Inc. (ACH) files with the SEC under industry code 5047, Wholesale-Medical, Dental & Hospital Equipment & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.8 billion and a net loss of $1.1 billion. Free cash flow was -$292.7 million. As of Jun 30, 2026 it held $7.7 million in cash and investments and $101.6 million in total debt.
Revenue (TTM)
$2.65B
-3.3% vs year-ago TTM
Net income (TTM)
$-302.14M
+74.9% vs year-ago TTM
Operating cash flow
$-101.79M
Free cash flow
$-292.75M
EPS (TTM)
$-3.94
+74.8% vs year-ago TTM
Dividend per share
$0.01
+0.0% vs prior year
Shares outstanding
76.44M
-1.0% vs prior year
Net cash
$-93.98M
as of Jun 30, 2026
Operating margin
1.1%
FY 2026
Company profile
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (SIC 5047)
- Listed as
- ACH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Glen Allen, VA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 75252
- Former names
- OWENS & MINOR INC/VA/ (until Dec 31, 2025); O&M HOLDING INC (until Jun 17, 1994); OWENS & MINOR INC (until Mar 9, 1994)
Other Wholesale-Medical, Dental & Hospital Equipment & Supplies companies
- Henry Schein Inc HSIC
- HengHong Technology Inc. HCPC
All 3 Wholesale-Medical, Dental & Hospital Equipment & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.8B | $2.7B | $2.6B | $10.0B | $9.8B |
| Operating income | $27.5M | -$217.7M | $133.2M | $142.9M | $368.5M |
| Net income | -$1.1B | -$362.7M | -$41.3M | $22.4M | $221.6M |
| Diluted EPS | -$14.31 | -$4.73 | -$0.53 | $0.29 | $2.94 |
| Operating cash flow | -$101.8M | — | — | — | — |
| Free cash flow | -$292.7M | — | — | — | — |
| Total assets | $2.5B | $4.7B | $5.1B | $5.4B | $3.5B |
| Total liabilities | $2.9B | $4.1B | $4.2B | $4.4B | $2.6B |
| Stockholders' equity | -$461.0M | $586.4M | $945.3M | $966.7M | $938.5M |
| Cash and investments | $282.0M | $27.6M | $243.0M | $69.5M | $55.7M |
| Total debt | $363.6M | $183.3M | $527.4M | $2.8B | $1.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 2, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 30, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 9, 2026 | Oct 6, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 28, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 17, 2026 | Sep 16, 2026 |
All 1000 Accendra Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.